MOSCOW -- The era that began with the end of the Second World War is now over. That period was characterized by a relatively orderly and stable system of confrontation. In fact, the end of the Cold War did not mean the emergence of a new order. There was a hope that the main centers of power would establish relations based largely on cooperation. Instead, an attempt was made to build a unipolar world, which predictably failed. To all appearances, the world is now being swept by a wave of turbulence and fierce competition, if not a struggle of all against all.
With the news that incumbent Nguyễn Phú Trong is poised to continue as General Secretary of the Viet Nam Communist Party, following a secretive leadership race with outgoing Prime Minister Nguyễn Tấn Dũng, he must urgently move to rehabilitate the country's longstanding appalling human rights record.
Our country's singular ability to attract FDI has delivered growth, prosperity, and jobs coming out of the greatest economic crisis since the Great Depression. And our continuing ability to ensure that the U.S. remains the top-global destination for FDI will be critical to furthering our future economic success and our ongoing global leadership.
The Obama administration surely negotiated the TPP in good faith, and the accord would likely add to global and U.S. economic growth. This is not a pernicious accord, the fruits of a secret cabal as some have feared. Nor is globalization an evil to be fought tooth and nail. The sad truth, however, is that while the administration promised a 21st-century agreement, we have yet another late 20th-century agreement.
Rather than continuing the forward momentum toward greater access to affordable medications for all, the TPP threatens to take a significant step backward by including a number of provisions that solely benefit the brand name drug industry. As drafted, the TPP will result in hundreds of billions of dollars in unnecessary spending.